Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling
Oncotarget (2016) - Comment
pubmed: 26575168  doi: 10.18632/oncotarget.6315  issn: 1949-2553 

Laura Mediani, Federica Gibellini, Jessika Bertacchini, Chiara Frasson, Raffaella Bosco, Benedetta Accordi, Giuseppe Basso, Massimo Bonora, Maria Luisa Calabrò, Adriana Mattiolo, Gianluca Sgarbi, Alessandra Baracca, Paolo Pinton, Giovanni Riva, Enrico Rampazzo, Luca Petrizza, Luca Prodi, Daniela Milani, Mario Luppi, Leonardo Potenza